Share on StockTwits

Aradigm (NASDAQ:ARDM) announced its earnings results on Thursday. The company reported ($0.09) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.09), AmericanBankingNews.com reports. The company had revenue of $12.20 million for the quarter, compared to the consensus estimate of $4.25 million.

Shares of Aradigm (NASDAQ:ARDM) traded up 0.24% on Thursday, hitting $8.52. The stock had a trading volume of 5,775 shares. Aradigm has a 1-year low of $6.80 and a 1-year high of $16.00. The stock’s 50-day moving average is $8.76 and its 200-day moving average is $9.26. The company’s market cap is $125.0 million.

Aradigm Corporation is a specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists.

Receive News & Ratings for Aradigm Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aradigm Co and related companies with Analyst Ratings Network's FREE daily email newsletter.